Report: J&J set for EU OK on Synthes buyout | Wall Street Beat March 19, 2012 By MassDevice staff Leave a Comment European Union regulators are poised to give the OK to Johnson & Johnson‘s (NYSE:JNJ) $21.3 billion acquisition of Swiss orthopedic giant Synthes, according to Reuters.